Skin Diseases  >>  Tepezza (teprotumumab-trbw)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tepezza (teprotumumab-trbw) / Roche, Amgen
NCT00882674 / 2008-004128-22: A Study to Evaluate the Biological Activity of R1507 in Women With Operable Breast Cancer

Completed
1
8
Europe
RG1507
Hoffmann-La Roche
Breast Cancer
12/10
12/10

Download Options